Annual report pursuant to Section 13 and 15(d)

Selected Quarterly Financial Data (unaudited)

v3.8.0.1
Selected Quarterly Financial Data (unaudited)
12 Months Ended
Dec. 31, 2017
Selected Quarterly Financial Data (unaudited)  
Selected Quarterly Financial Data (unaudited)

15. Selected Quarterly Financial Data (unaudited)

The following table contains selected quarterly financial information for 2017 and 2016. The Company believes that the following information reflects all normal recurring adjustments necessary for a fair statement of the information for the periods presented. The operating results for any quarter are not necessarily indicative of results for any future period.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

    

March 31, 2017

    

June 30, 2017

    

September 30, 2017

    

December 31, 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

1,101

 

$

 —

 

$

 —

 

$

 —

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

9,628

 

 

10,041

 

 

10,447

 

 

11,780

 

General and administrative

 

 

3,086

 

 

3,472

 

 

3,593

 

 

3,740

 

Total operating expenses

 

 

12,714

 

 

13,513

 

 

14,040

 

 

15,520

 

Loss from operations

 

 

(11,613)

 

 

(13,513)

 

 

(14,040)

 

 

(15,520)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income, net

 

 

98

 

 

145

 

 

215

 

 

218

 

Net loss applicable to common stockholders

 

$

(11,515)

 

$

(13,368)

 

$

(13,825)

 

$

(15,302)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share applicable to common stockholders - basic and diluted

 

$

(0.49)

 

$

(0.52)

 

$

(0.53)

 

$

(0.58)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted

 

 

23,393,448

 

 

25,584,147

 

 

26,259,216

 

 

26,316,550

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

    

March 31, 2016

    

June 30, 2016

    

September 30, 2016

    

December 31, 2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

 —

 

$

 —

 

$

 —

 

$

317

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

8,265

 

 

9,525

 

 

11,584

 

 

8,443

 

General and administrative

 

 

2,371

 

 

2,540

 

 

2,633

 

 

2,919

 

Total operating expenses

 

 

10,636

 

 

12,065

 

 

14,217

 

 

11,362

 

Loss from operations

 

 

(10,636)

 

 

(12,065)

 

 

(14,217)

 

 

(11,045)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income, net

 

 

48

 

 

44

 

 

48

 

 

80

 

Net loss

 

$

(10,588)

 

$

(12,021)

 

$

(14,169)

 

$

(10,965)

 

Accrued dividends on preferred stock

 

 

(1,737)

 

 

(1,823)

 

 

(121)

 

 

 —

 

Net loss applicable to common stockholders

 

$

(12,325)

 

$

(13,844)

 

$

(14,290)

 

$

(10,965)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share applicable to common stockholders - basic and diluted

 

$

(5.15)

 

$

(5.42)

 

$

(0.65)

 

$

(0.47)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted

 

 

2,394,470

 

 

2,553,146

 

 

22,012,743

 

 

23,374,734